首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >Increased postoperative respiratory complications in heterotaxy congenital heart disease patients with respiratory ciliary dysfunction
【24h】

Increased postoperative respiratory complications in heterotaxy congenital heart disease patients with respiratory ciliary dysfunction

机译:异位先天性心脏病合并呼吸道睫状功能障碍的患者术后呼吸道并发症增加

获取原文
获取原文并翻译 | 示例
           

摘要

Objective(s) Congenital heart disease (CHD) and heterotaxy patients have increased postoperative and respiratory complications. We recently showed CHD-heterotaxy patients can have respiratory ciliary dysfunction (CD) similar to that associated with primary ciliary dyskinesia, including low nasal nitric oxide and abnormal ciliary motion. In this study, we investigated whether CHD-heterotaxy patients with CD may have worse postsurgical outcomes. Methods We examined postsurgical outcome in 13 heterotaxy-CHD patients with CD (25 surgeries), compared with 14 heterotaxy-CHD patients without CD (27 surgeries). Outcome data were collected for each surgery, including respiratory complications, tracheostomy, use of inhaled β-agonists or nitric oxide, length of hospital stay, days on ventilator, and death. Results The CD versus the no-CD CHD cohorts had similar Risk Adjustment in Congenital Heart Surgery-1 risk categories, repair track, age at surgery, and follow-up evaluation times. Respiratory complications (76% vs 37%; P =.006), need for tracheostomy (16% vs 0%; P =.047), and use of inhaled β-agonists (64% vs 11%; P =.0001) all were increased significantly in heterotaxy-CHD patients with CD. No significant differences were detected in postoperative hospital stay, days on mechanical ventilation, or surgical mortality. A trend toward increased mortality for the CD group beyond the postoperative period was observed (33% vs 0%; P =.055) in patients younger than age 10 years. Conclusions Our findings showed that heterotaxy-CHD patients with CD may have increased risks for respiratory deficiencies. Overall, there was a trend toward increased mortality in CD patients with intermediate follow-up evaluation. Because β-agonists are known to increase ciliary beat frequency, presurgical screening for CD and perioperative treatment of CD patients with inhaled β-agonists may improve postoperative outcomes and survival.
机译:目的先天性心脏病(CHD)和异型患者的术后和呼吸系统并发症增加。我们最近显示,冠心病异位症患者可患有与原发性睫状运动障碍相关的呼吸道睫状功能障碍(CD),包括低的一氧化氮和异常的睫状运动。在这项研究中,我们调查了患有CD的CHD异位症患者是否可能具有较差的术后预后。方法我们检查了13例CD杂合性CHD患者(25例手术)的术后结局,而14例无CD杂合性CHD患者(27例手术)。收集每项手术的结果数据,包括呼吸系统并发症,气管切开术,使用吸入的β-激动剂或一氧化氮,住院时间长,呼吸机使用天数和死亡。结果CD与非CD CHD队列在先天性心脏病1风险类别,修复轨迹,手术年龄和随访评估时间方面具有相似的风险调整。呼吸系统并发症(76%vs 37%; P = .006),需要进行气管切开术(16%vs 0%; P = .047),以及使用吸入性β-激动剂(64%vs 11%; P = .0001)异位性冠心病合并CD的患者均明显增加。术后住院时间,机械通气天数或手术死亡率均无显着差异。在年龄小于10岁的患者中,观察到CD组术后期死亡率增加的趋势(33%vs 0%; P = .055)。结论我们的研究结果表明,患有CD的异源性CHD患者可能会增加呼吸系统缺陷的风险。总体而言,在进行中期随访评估后,CD患者的死亡率有增加的趋势。由于已知β激动剂会增加纤毛搏动的频率,因此对CD进行术前筛查以及对吸入β激动剂的CD患者进行围手术期治疗可能会改善术后结果和生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号